In what year did the FDA approve cochlear implants for single-sided deafness?

The FDA approved cochlear implants for single-sided deafness in 2019. This marked an important advancement in audiological treatment options, allowing patients with hearing loss in one ear and normal hearing in the other to benefit from cochlear implants. This decision opened the door for an expanded range of treatment for those with this condition, improving communication abilities and overall quality of life for many individuals suffering from single-sided deafness. The approval reflects ongoing research and clinical trials that demonstrated the efficacy of cochlear implants in addressing this specific type of hearing loss, highlighting the FDA's commitment to ensuring that innovative medical devices are approved based on comprehensive evidence of their benefits.